Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-serine and Cranial Nerve II Injuries

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Cranial Nerve II Injuries in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bähr, M; Choi, BK; D'Onofrio, PM; Koeberle, PD; Shabanzadeh, AP1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Cranial Nerve II Injuries

ArticleYear
MMP Inhibition Preserves Integrin Ligation and FAK Activation to Induce Survival and Regeneration in RGCs Following Optic Nerve Damage.
    Investigative ophthalmology & visual science, 2019, 02-01, Volume: 60, Issue:2

    Topics: Animals; Blotting, Western; Cell Count; Cell Survival; Extracellular Matrix; Female; Focal Adhesion Protein-Tyrosine Kinases; Immunohistochemistry; Integrin beta1; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Microscopy, Confocal; Microscopy, Fluorescence; Nerve Crush; Oligopeptides; Optic Nerve Injuries; Phosphorylation; Rats; Rats, Sprague-Dawley; Regeneration; Retinal Ganglion Cells

2019